
Sign up to save your podcasts
Or
Formation Bio, a startup with backing from Open AI CEO Sam Altman, has announced a raise of $372 million to boost drug development using artificial intelligence. But what are the potential ethical and legal risks associated with this?
GUEST: Emily Casey, self-described Medicine Defector, Head of Community at Tenmile and Founder of ‘What the Health’
4.4
88 ratings
Formation Bio, a startup with backing from Open AI CEO Sam Altman, has announced a raise of $372 million to boost drug development using artificial intelligence. But what are the potential ethical and legal risks associated with this?
GUEST: Emily Casey, self-described Medicine Defector, Head of Community at Tenmile and Founder of ‘What the Health’
68 Listeners
86 Listeners
50 Listeners
15 Listeners
19 Listeners
94 Listeners
15 Listeners
49 Listeners
7 Listeners
0 Listeners
4 Listeners
85 Listeners
57 Listeners
9 Listeners
11 Listeners
13 Listeners
130 Listeners
287 Listeners
8 Listeners
77 Listeners
6 Listeners
59 Listeners
2 Listeners
1 Listeners
47 Listeners